Hyperfractionated radiotherapy alone for clinical Stage I nonsmall cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 3, 1997, Pages 521-525

  Jeremic, Branislav ^a   Shibamoto, Yuta ^b   Acimovic, Ljubisa ^a   Milisavljevic, Slobodan ^a  

^a University Hospital   (Yugoslavia)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Hyperfractionated radiotherapy; Nonsmall cell lung cancer; Radiotherapy; Stage I

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; LINEAR ACCELERATOR; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME;

AGED; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE;

EID: 0030795703     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00098-9     Document Type: Article

References (21)

1. Byhardt, R. W. The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1513-1525; 1995.
2. Cooper, J. D.; Pearson, F. G.; Todd, T. R. J.; Patterson, G. A.; Ginsberg, R. J.; Basiuk, J.; Blair, V.; Cass, W. Radiotherapy alone for patients with operable carcinoma of the lung. Chest 87:289-292; 1985.
3. Cox, J. D.; Azarnia, N.; Byhardt, R. W.; Shin, K. H.; Emami, B.; Pajak, T. F. A randomized Phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥ 69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8:1543-1555; 1990.
4. Dosoretz, D. E.; Katin, M. J.; Blitzer, P. H.; Rubenstein, J. H.; Galmarini, D. H.; Garton, G. R.; Salenius, S. A. Medically inoperable lung carcinoma: The role of radiation therapy. Semin. Radiat. Oncol. 6:98-104; 1996.
5. Dosoretz, D. E.; Katin, M. J.; Blitzer, P. H.; Rubenstein, J. H.; Salenius, S. A.; Rashid, M.; Dosani, R. A.; Mestas, G.; Siegel, A. D.; Chadha, T. T.; Chandrahasa, T.; Hannan, S. E.; Bhat, S. B.; Metke, M. P. Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int. J. Radiat. Oncol. Biol. Phys. 24:3-9; 1992.
6. Gauden, S.; Ramsay, J.; Tripcony, L. The curative treatment by radiotherapy alone of Stage I non-small cell carcinoma of the lung. Chest 108:1278-1282; 1995.
7. Graham, P. H.; Gebski, V. J.; Langlands, A. O. Radical radiotherapy for early nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 31:261-266; 1995.
8. Haffty, B. G.; Goldberg, N. B.; Gerstley, J.; Fischer, D. B.; Peschel, R. E. Results of radical radiation therapy in clinical Stage I, technically operable non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 15:69-73; 1988.
9. Hayakawa, K.; Mitsuhashi, N.; Nakajima, N.; Saito, Y.; Mitomo, O.; Nakayama, Y.; Katano, S.; Niibe, H. Radiation therapy for Stage I-III epidermoid carcinoma of the lung. Lung Cancer 8:213-224; 1992.
10. Jeremic, B.; Shibamoto, Y. Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for Stage III nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 34:303-308; 1996.
11. Jeremic, B.; Shibamoto, Y.; Acimovic, L.; Djuric, L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J. Clin. Oncol. 13:452-458; 1995.
12. Jeremic, B.; Shibamoto, Y.; Acimovic, L.; Milisavljevic, S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study. J. Clin. Oncol. 14:1065-1070; 1996.
13. Kaskowitz, L.; Graham, M. V.; Emami, B.; Halverson, K. J.; Rush, C. Radiation therapy alone for Stage I non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 27:517-523; 1993.
14. Krol, A. D. G.; Aussems, P.; Noordijk, E. M.; Hermans, J.; Leer, J. W. H. Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation? Int. J. Radiat. Oncol. Biol. Phys. 34:297-302; 1996.
15. Noordijk, E. M.; Poest Clement, E. V. D.; Hermans, J.; Wever, A. M. J.; Leer, J. W. H. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother. Oncol. 13:83-89; 1988.
16. Sandler, H. M.; Curran, W. J. Jr.; Turrisi, A. T. III. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for Stage I non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 19:9-13; 1990.
17. Sause, W. T.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Emami, B.; Curran, W. J.; Byhardt, R. W.; Turrisi, A. T.; Dar, A. R.; Cox, J. D. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a Phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J. Natl. Cancer Inst. 87:198-205; 1995.
18. Slotman, B. J.; Njo, K. H.; Karim, A. B. M. F. Curative radiotherapy for technically operable Stage I nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 29:33-37; 1994.
19. Talton, B. M.; Constable, W. C.; Kersh, C. R. Curative radiotherapy in non-small cell carcinoma of the lung. Int. J. Radiat. Oncol. Biol. Phys. 19:15-21; 1990.
20. Würschmidt, F.; Bünemann, H.; Bünemann, C.; Beck-Bornholdt, H. P.; Heilmann, H. P. Inoperable non-small cell lung cancer: A retrospective analysis of 427 patients treated with high-dose radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 28:583-588; 1994.
21. Zhang, H. X.; Yin, W. B.; Zhang, L. J.; Yang, Z. Y.; Zhang, Z. X.; Wang, M.; Chen, D. F.; Gu, X. Z. Curative radiotherapy of early operable non-small cell lung cancer. Radiother. Oncol. 14:89-94; 1989.